Detalhe da pesquisa
1.
Validation of randomized controlled trial-derived models for the prediction of postintervention outcomes in chronic limb-threatening ischemia.
J Vasc Surg
; 71(3): 869-879, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31564582
2.
High and immeasurable ankle-brachial index as predictor of poor amputation-free survival in critical limb ischemia.
J Vasc Surg
; 67(6): 1864-1871.e3, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29290494
3.
Arterial calcification and long-term outcome in chronic limb-threatening ischemia patients.
Eur J Radiol
; 132: 109305, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33007520
4.
10-Year Paclitaxel Dose-Related Outcomes of Drug-Eluting Stents Treated Below the Knee in Patients with Chronic Limb-Threatening Ischemia (The PADI Trial).
Cardiovasc Intervent Radiol
; 43(12): 1881-1888, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-32725411
5.
Cost-Effectiveness of Drug-Eluting Stents for Infrapopliteal Lesions in Patients with Critical Limb Ischemia: The PADI Trial.
Cardiovasc Intervent Radiol
; 43(3): 376-381, 2020 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-31807849
6.
Long-Term Follow-up of the PADI Trial: Percutaneous Transluminal Angioplasty Versus Drug-Eluting Stents for Infrapopliteal Lesions in Critical Limb Ischemia.
J Am Heart Assoc
; 6(4)2017 Apr 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-28411244
7.
Diabetes Is Associated With Decreased Limb Survival in Patients With Critical Limb Ischemia: Pooled Data From Two Randomized Controlled Trials.
Diabetes Care
; 39(11): 2058-2064, 2016 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-27612499
8.
Percutaneous Transluminal Angioplasty and Drug-Eluting Stents for Infrapopliteal Lesions in Critical Limb Ischemia (PADI) Trial.
Circ Cardiovasc Interv
; 9(2): e002376, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26861113